Log In
Print
BCIQ
Print
Print this Print this
 

DP-4088

  Manage Alerts
Collapse Summary General Information
Company Diakron Pharmaceutical Inc.
DescriptionOral direct thrombin inhibitor (DTI)
Molecular Target Thrombin (Factor IIa) (F2)
Mechanism of ActionThrombin inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationThrombosis
Indication DetailsTreat thrombosis
Regulatory Designation

Partner

Orchid Chemicals & Pharmaceuticals Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today